202 related articles for article (PubMed ID: 25970959)
1. Clinico-epidemiological study of endometrial hyperplasia--a risk factor for the development of endometrial carcinoma?
Cărăuleanu A; Lupaşcu IA; Cărăuleanu DM; Socolov R; Socolov D
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):154-61. PubMed ID: 25970959
[TBL] [Abstract][Full Text] [Related]
2. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
Mittal K; Da Costa D
Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
[TBL] [Abstract][Full Text] [Related]
3. Risk for advanced-stage endometrial cancer in surgical specimens from patients with complex endometrial hyperplasia with atypia.
Eddib A; Allaf B; Lee J; Yeh J
Gynecol Obstet Invest; 2012; 73(1):38-42. PubMed ID: 22056948
[TBL] [Abstract][Full Text] [Related]
4. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
5. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia.
Ip PP; Irving JA; McCluggage WG; Clement PB; Young RH
Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295
[TBL] [Abstract][Full Text] [Related]
6. Incidence of endometrial carcinoma in patients with endometrial hyperplasia.
Novac L; Grigore T; Cernea N; Niculescu M; Cotarcea S
Eur J Gynaecol Oncol; 2005; 26(5):561-3. PubMed ID: 16285581
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
8. Concomitant endometrial hyperplasia in patients with endometrial carcinoma.
Gücer F; Reich O; Tamussino K; Bader AA; Pieber D; Schöll W; Haas J; Petru E
Gynecol Oncol; 1998 Apr; 69(1):64-8. PubMed ID: 9571000
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
Garuti G; Mirra M; Luerti M
J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
[TBL] [Abstract][Full Text] [Related]
10. [Incidence of endometrial carcinoma after hysterectomy for atypical hyperplasia or FIGO stage IA carcinoma diagnosed on endometrial biopsy or endometrial resection].
Ploteau S; Squifflet JL; Berlière M; Marbaix E; Donnez J
Bull Cancer; 2008 May; 95(5):556-62. PubMed ID: 18541521
[TBL] [Abstract][Full Text] [Related]
11. Endometrial hyperplasia and neoplasia. Cytologic screening with the Endopap endometrial sampler.
Meisels A; Fortier M; Jolicoeur C
J Reprod Med; 1983 May; 28(5):309-13. PubMed ID: 6152983
[TBL] [Abstract][Full Text] [Related]
12. Presence of endometrial adenocarcinoma in situ in complex atypical endometrial hyperplasia is associated with increased incidence of endometrial carcinoma in subsequent hysterectomy.
Mittal K; Sebenik M; Irwin C; Yan Z; Popiolek D; Curtin J; Palazzo J
Mod Pathol; 2009 Jan; 22(1):37-42. PubMed ID: 19116629
[TBL] [Abstract][Full Text] [Related]
13. Endometrial carcinoma associated with hyperplasia.
Kaku T; Tsukamoto N; Hachisuga T; Tsuruchi N; Sakai K; Hirakawa T; Amada S; Saito T; Kamura T; Nakano H
Gynecol Oncol; 1996 Jan; 60(1):22-5. PubMed ID: 8557221
[TBL] [Abstract][Full Text] [Related]
14. Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia.
Hahn HS; Chun YK; Kwon YI; Kim TJ; Lee KH; Shim JU; Mok JE; Lim KT
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):80-3. PubMed ID: 20185225
[TBL] [Abstract][Full Text] [Related]
15. The prognostic and therapeutic implications of cytologic atypia in patients with endometrial hyperplasia.
Hunter JE; Tritz DE; Howell MG; DePriest PD; Gallion HH; Andrews SJ; Buckley SB; Kryscio RJ; van Nagell JR
Gynecol Oncol; 1994 Oct; 55(1):66-71. PubMed ID: 7959270
[TBL] [Abstract][Full Text] [Related]
16. Descriptive epidemiology of endometrial hyperplasia in patients with abnormal uterine bleeding.
Anastasiadis PG; Skaphida PG; Koutlaki NG; Galazios GC; Tsikouras PN; Liberis VA
Eur J Gynaecol Oncol; 2000; 21(2):131-4. PubMed ID: 10843470
[TBL] [Abstract][Full Text] [Related]
17. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
[TBL] [Abstract][Full Text] [Related]
18. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of underlying adenocarcinoma in women with atypical endometrial hyperplasia.
Shutter J; Wright TC
Int J Gynecol Pathol; 2005 Oct; 24(4):313-8. PubMed ID: 16175074
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological analysis in cases with glandular and atypical glandular hyperplasia treated with gestagens].
Ivanov S
Akush Ginekol (Sofiia); 2005; 44(4):18-20. PubMed ID: 16028373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]